Cost-Effectiveness of Providing the Depression Care for People With Cancer Program to Patients With Prostate Cancer in the United States

Watts, 2014, Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates, BMJ Open, 4, 10.1136/bmjopen-2013-003901 Erim, 2019, Prevalence and predictors of probable depression in prostate cancer survivors, Cancer, 125, 3418, 10.1002/cncr.32338 Addis, 2003, Men, masculinity, and the contexts of help seeking, Amer Psychol, 58, 5, 10.1037/0003-066X.58.1.5 Matthew, 2014, Men’s mental health: Connection to urologic health, Can Urol Assoc J, 8, S153, 10.5489/cuaj.2312 Akincigil, 2017, National rates and patterns of depression screening in primary care: results from 2012 and 2013, J Psychiatr Serv, 68, 660, 10.1176/appi.ps.201600096 Mitchell, 2009, Clinical diagnosis of depression in primary care: a meta-analysis, Lancet, 374, 609, 10.1016/S0140-6736(09)60879-5 Erim, 2019, Patterns and predictors of self-reported clinical diagnosis and treatment for depression in prostate cancer survivors, Cancer Med, 8, 3648, 10.1002/cam4.2239 Erim, 2018 Skolarus, 2014, American Cancer Society prostate cancer survivorship care guidelines. CA, Cancer J Clin, 64, 225, 10.3322/caac.21234 Walker, 2009, Depression care for people with cancer: a collaborative care intervention, Gen Hosp Psychiatry, 31, 436, 10.1016/j.genhosppsych.2009.05.010 Sharpe, 2014, Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial, Lancet, 384, 1099, 10.1016/S0140-6736(14)61231-9 Walker, 2014, Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer, Lancet Oncol, 15, 1168, 10.1016/S1470-2045(14)70343-2 Duarte, 2015, Cost-effectiveness of integrated collaborative care for comorbid major depression in patients with cancer, J Psychosom Res, 79, 465, 10.1016/j.jpsychores.2015.10.012 Walker, 2014, Cost-effectiveness of combining systematic identification and treatment of co-morbid major depression for people with chronic diseases: the example of cancer, Psychol Med, 44, 1451, 10.1017/S0033291713002079 Brawley, 2012, Trends in prostate cancer in the United States, J Natl Cancer Inst Monogr, 45, 152, 10.1093/jncimonographs/lgs035 Harding Kruijshaar, 2005, Lifetime prevalence estimates of major depression: an indirect estimation method and a quantification of recall bias, Eur J Epidemiol, 20, 103, 10.1007/s10654-004-1009-0 Patten, 2006, A major depression prognosis calculator based on episode duration, J Clin Practice, 2, 13, 10.1186/1745-0179-2-13 Pence, 2012, The depression treatment cascade in primary care: a public health perspective, Curr Psychiatry Reports, 1 Mitchell, 2011, Screening for distress and depression in cancer settings: 10 lessons from 40 years of primary-care research, Psycho-Oncology, 20, 572, 10.1002/pon.1943 Klabunde, 2009, The role of primary care physicians in cancer care, J Gen Intern Med, 24, 1029, 10.1007/s11606-009-1058-x Pirl, 2014, Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force, Cancer, 120, 2946, 10.1002/cncr.28750 Zebrack, 2017, A practice-based evaluation of distress screening protocol adherence and medical service utilization, J Natl Compr Canc Netw, 15, 903, 10.6004/jnccn.2017.0120 Kroenke, 2002, The PHQ-9: a new depression diagnostic and severity measure, Psychiatr Ann, 32, 509, 10.3928/0048-5713-20020901-06 Chambers, 2014, The validity of the distress thermometer in prostate cancer populations, Psychooncology, 23, 195, 10.1002/pon.3391 Richards, 2019, An integrated care approach to identifying and treating the suicidal person in primary care, Psychiatric Times Blier, 2007, Preventing recurrent depression: long-term treatment for major depressive disorder, J Clin Psychiatry, 68, 10.4088/JCP.0307e06 Sim, 2016, Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta-analyses of controlled trials, Int J Neuropsychopharmacol, 19, 10.1093/ijnp/pyv076 Cipriani, 2018, Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis, Lancet, 391, 1357, 10.1016/S0140-6736(17)32802-7 Cuijpers, 2010, The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size, Psychol Med, 40, 211, 10.1017/S0033291709006114 Cuijpers, 2010, Psychotherapy for chronic major depression and dysthymia: a meta-analysis, Clin Psychol Rev, 30, 51, 10.1016/j.cpr.2009.09.003 Gelenberg, 2010, Practice guideline for the treatment of patients with major depressive disorder, third edition, Amer J Psychiatry, 167, 1 Kovich, 2015, Common questions about the pharmacologic management of depression in adults, Amer Fam Physician, 92 Valenstein, 2012, Antidepressant agents and suicide death among US Department of Veterans Affairs patients in depression treatment, J Clin Psychopharmacol, 32, 346, 10.1097/JCP.0b013e3182539f11 Nieuwsma, 2012, Brief psychotherapy for depression: a systematic review and meta-analysis, Int J Psychiatry Med, 43, 129, 10.2190/PM.43.2.c Sirey, 2017, Adherence to depression treatment in primary care: a randomized clinical trial, JAMA Psychiatry, 74, 1129, 10.1001/jamapsychiatry.2017.3047 Sanders, 2016, Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine, JAMA, 316, 1093, 10.1001/jama.2016.12195 Barton, 2008, Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI), Value Health, 11, 886, 10.1111/j.1524-4733.2008.00358.x Petterson, 2012, Projecting US primary care physician workforce needs: 2010-2025, Ann Fam Med, 10, 503, 10.1370/afm.1431 Valenstein, 2001, The cost–utility of screening for depression in primary care, Ann Intern Med, 134, 345, 10.7326/0003-4819-134-5-200103060-00007 Nguyen, 2015, Cost-effectiveness of repetitive transcranial magnetic stimulation versus antidepressant therapy for treatment-resistant depression, J Value Health, 18, 597 Williams, 2018, Incidence and method of suicide in hospitals in the United States, Jt Comm J Qual Patient Saf, 44, 643 Deisenhammer, 2000, In-patient suicide in psychiatric hospitals, J Acta Psychiatr Scand, 102, 290, 10.1034/j.1600-0447.2000.102004290.x Valenstein, 2009, Higher-risk periods for suicide among VA patients receiving depression treatment: prioritizing suicide prevention efforts, J Affect Disord, 112, 50, 10.1016/j.jad.2008.08.020 Bremner, 2007, A review and meta-analysis of prostate cancer utilities, J Med Decis Making, 27, 288, 10.1177/0272989X07300604 Saarni, 2006, The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D, Qual Life Res, 15, 1403, 10.1007/s11136-006-0020-1 Greenberg, 2015, The economic burden of adults with major depressive disorder in the United States (2005 and 2010), J Clin Psychiatry, 76, 155, 10.4088/JCP.14m09298 Coleman, 2017, Most frequently used CPT codes by Clinical Social Workers Stensland, 2012, An examination of costs, charges, and payments for inpatient psychiatric treatment in community hospitals, Psych Ser, 63, 666, 10.1176/appi.ps.201100402 Karasu TB, et al. Treatment of patients with major depressive disorder. American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders Compendium. 2000:413-495. Arias, 2019 Balasubramanian, 2016 Patel, 2018, Demographic pattern and hospitalization outcomes of depression among 2.1 million Americans with four major cancers in the United States, Med Sci, 6, 93 Stewart, 2005, Utilities for prostate cancer health states in men aged 60 and older, J Med Care, 347 Sullivan, 2004, A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions, CNS Drugs, 18, 911, 10.2165/00023210-200418130-00006 Coupland, 2011, Antidepressant use and risk of adverse outcomes in older people: population based cohort study, BMJ, 343, d4551, 10.1136/bmj.d4551 Torrance, 1989, Utilities and quality-adjusted life years, Int J Tech Assess Health Care, 5, 559, 10.1017/S0266462300008461 Fu, 2008, Utilities should not be multiplied: evidence from the preference-based scores in the United States, Med Care, 46, 984, 10.1097/MLR.0b013e3181791a9c Naimark, 2008, The half-cycle correction explained: two alternative pedagogical approaches, Med Decision Making, 28, 706, 10.1177/0272989X08315241 Wang, 2018, Comparing the ICERs in medicine reimbursement submissions to NICE and PBAC—does the presence of an explicit threshold affect the ICER proposed?, Value Health, 21, 938, 10.1016/j.jval.2018.01.017 Pandya, 2018, Adding cost-effectiveness to define low-value care, JAMA, 319, 1977, 10.1001/jama.2018.2856 Siu, 2016, Screening for depression in adults: US Preventive Services Task Force recommendation statement, JAMA, 315, 380, 10.1001/jama.2015.18392 DiMatteo, 2000, Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence, Arch Intern Med, 160, 2101, 10.1001/archinte.160.14.2101 Masand, 2003, Tolerability and adherence issues in antidepressant therapy, Clin Therapeutics, 25, 2289, 10.1016/S0149-2918(03)80220-5 Llorente, 2005, Prostate cancer: a significant risk factor for late-life suicide, Amer J Geriatr Psychiatry, 13, 195, 10.1097/00019442-200503000-00004 Friberg, 2019, Educational level and the risk of depression after prostate cancer, Acta Oncol, 58, 722, 10.1080/0284186X.2019.1566773 Riihimäki, 2014, Incidence and predictors of suicide attempts among primary-care patients with depressive disorders: a 5-year prospective study, Psychol Med, 44, 291, 10.1017/S0033291713000706 Mulick, 2018, Does depression treatment improve the survival of depressed patients with cancer? a long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials, Lancet Psychiatry, 5, 321, 10.1016/S2215-0366(18)30061-0 Shrank, 2019, Waste in the US health care system: estimated costs and potential for savings, JAMA, 332, 1501, 10.1001/jama.2019.13978 Chisholm, 2016, Scaling-up treatment of depression and anxiety: a global return on investment analysis, Lancet Psychiatry, 3, 415, 10.1016/S2215-0366(16)30024-4 Birnbaum, 2010, Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance, J Depress Anxiety, 27, 78, 10.1002/da.20580 Luppa, 2008, Healthcare costs associated with recognized and unrecognized depression in old age, Int Psychogeriatr, 20, 1219, 10.1017/S1041610208007680 Melek, 2012 Strong, 2008, Management of depression for people with cancer (SMaRT oncology 1): a randomised trial, Lancet, 372, 40, 10.1016/S0140-6736(08)60991-5 Buntrock, 2017, Preventing depression in adults with subthreshold depression: health-economic evaluation alongside a pragmatic randomized controlled trial of a web-based intervention, J Med Internet Res, 19, e5, 10.2196/jmir.6587 Lee, 2018, The risk of developing major depression among individuals with subthreshold depression: a systematic review and meta-analysis of longitudinal cohort studies, Psychol Med, 1